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SUMMARY – Waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio 
(WHtR) are superior to body mass index (BMI) in predicting type 2 diabetes mellitus (T2DM) 
 development. Th e aim of this study was to investigate the predictive power of BMI, WC, WHR and 
WHtR for microvascular (chronic kidney disease (CKD), retinopathy and peripheral neuropathy) 
prevalence in obese (BMI ≥35 kg/m2) T2DM patients. Th is cross-sectional study included 125 T2DM 
patients of both genders. Th e validity of each test was assessed by Receiver Operating Characteristic 
(ROC) curves; the area under the curve (AUC) was calculated for each anthropometric parameter and 
microvascular complication. AUCs for WHtR were signifi cantly higher than AUCs for WC with 
respect to CKD. Optimal cut-off  for WHtR was >0.593 and WC >112 cm regarding CKD. Th e AUC 
for peripheral neuropathy was signifi cant only for WHR and optimal cut-off  for WHR was >1.409 
with low sensitivity and high specifi city. Our study demonstrated that WHtR, WC and WHR might 
be used as simple and noninvasive methods for detection of CKD and peripheral neuropathy in obese 
T2DM population.
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Introduction
Obesity is considered to be the major risk factor for 
type 2 diabetes mellitus (T2DM) development, the 
estimated prevalence of which was 8.5% in Europe in 
2013, while this population continues to develop dia-
betic macro- and microvascular complications result-
ing in increased disability and enormous healthcare 
costs1,2. Several study reports suggest that fat distribu-
tion is important as a risk factor for T2DM develop-
ment, i.e. anthropometric measurements that describe 
central or ‘android fat’ distribution are superior to gen-
eral obesity measurements in predicting T2DM3-7. 
Anthropometric measurements are commonly used to 
assess disease risk factors as they are easy to monitor at 
the community level, as well as in large epidemiologic 
studies in order to predict T2DM development8. Body 
mass index (BMI) relates weight to height and was 
most frequently used to estimate the prevalence of 
obesity within a population; while BMI ≥25 kg/m2 is 
associated with increased T2DM morbidity, BMI ≥30 
kg/m2 is associated with an increased risk of morbidity 
and mortality from diabetes and its complications9,10. 
However, BMI refl ects total body fat and does not dis-
tinguish diff erent patterns of fat distribution11. Waist 
circumference (WC) and waist-to-hip ratio (WHR) 
have been proposed as tools to detect central obesity 
but taking into consideration that WC might over- or 
under-evaluate the risk for tall or short individuals 
with similar WC and that WHR has a limitation in 
case of weight loss when both sizes decrease but 
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changes in the ratio remain rather small12. Waist-to-
height ratio (WHtR) is another anthropometric mea-
surement of central obesity that corrects WC for 
height and is supported as an index that can be used in 
diff erent ethnic, age and sex groups for central obesity 
screening13-15.
Th e relationship between metabolic control and 
development of microvascular complications (retinop-
athy, neuropathy and nephropathy) is a primary con-
cern of clinicians. Factors involved in the development 
of vascular complications in diabetes include duration 
of diabetes, poor glycemic control, smoking, hyperten-
sion and dyslipidemia, but the role of body weight/
body fat distribution is unclear16. Th ere is a possible 
eff ect of BMI on retinopathy in diabetic patients, de-
rived primarily from Diabetes Control and Complica-
tions Trial (DCCT)17, where BMI was observed to 
have a signifi cant predictive value in developing reti-
nopathy besides the traditional factors, as later con-
fi rmed by Henricsson et al.18. Only a few recent reports 
suggest a role of BMI in neuropathy development 19,20. 
However, there are several studies linking obesity to 
chronic kidney disease (CKD) in diabetic patients21,22. 
Moreover, recent data suggest that central obesity 
might play a key role in associating obesity with the 
risk of microvascular complications, acting through 
several diff erent pathophysiological pathways23-26.
Th e aim of our study was to investigate the predic-
tive power of BMI, WC, WHR and WHtR for the 
prevalence of microvascular complications (CKD, reti-
nopathy and peripheral neuropathy) in obese (BMI 
≥35 kg/m2) T2DM patients.
Patients and Methods
Th is was a cross-sectional study including a sample 
of 125 T2DM consecutive patients of both genders 
presenting for complete annual check-up at our Clinic 
for Diabetes, Endocrinology and Metabolic Diseases. 
Patients with kidney (other than diabetic nephropa-
thy) and liver disorders, psychiatric diseases, non-es-
sential hypertension, or any chronic or acute infection 
were not included in the study. Th e study protocol 
complied with the Declaration of Helsinki, as well as 
with local institutional guidelines, and was approved 
by the local ethics committees. A written informed 
consent was obtained from all participants.
All subjects were studied in the morning between 
07:00 and 08:30 AM after an overnight fast. Baseline 
anthropometric measurements were performed in all 
study subjects by the same physician. WC was mea-
sured on bare skin as the narrowest circumference be-
tween the 10th rib and the iliac crest with tailor meter. 
Weight was measured by the physician using a bal-
anced-beam scale with light clothing without shoes 
and expressed in kilograms (kg) and height was mea-
sured using a wall-mounted stadiometer and expressed 
in centimeters (cm) according to the Th ird National 
Health and Nutrition Examination Survey (NHANES 
III) study27. A steel tape measure was used to measure 
female WC, midway between the lower rib margin 
and the iliac crest, and hip circumference at the widest 
point between the iliac crest and buttock. Th e circum-
ferences were measured in standing position and to 
the nearest 0.5 cm. BMI was calculated as weight in 
kilograms divided by the square of height in meters 
(kg/m2). WHR and WHtR were calculated by di-
viding WC by hip circumference and body height, 
 respectively.
Urine albumin excretion (UAE) was measured from 
at least two 24-h urine samples and determined as the 
mean of 24-h urine on two consecutive days to mini-
mize variability. Serum creatinine was measured in 
fasting blood sample. Data on serum creatinine levels, 
age, sex and race were used to calculate the estimated 
glomerular fi ltration rate (eGFR) using the Chronic 
Kidney Disease Epidemiology Collaboration (CKD-
-EPI) formula to determine the presence of diabetic 
nephropathy29. CKD was defi ned as the presence of 
impaired eGFR (less than 60 mL/min-11.73m-2) and/
or macroalbuminuria (UAE ≥300 mg/24 h). Retinopa-
thy was diagnosed by binocular indirect slit lamp fun-
duscopy and fundus photography after mydriasis with 
eye drops containing 0.5% tropicamide and 5% phen-
ylephrine. Color fundus photographs of two fi elds of 
both eyes were taken with a suitable 45° fundus camera 
(VISUCAM, Zeiss, Germany) according to the EU-
RODIAB retinal photography methodology28. In each 
patient, the ‘worse’ eye was graded for retinopathy 
 using fundus photographs. Evaluation of peripheral 
neuropathy was based on clinical symptoms (neuro-
pathy symptom score), signs (neuropathy disability 
score), quantitative sensory testing (vibration percep-
tion threshold), and electroneuromyography testing 
was performed to detect peripheral sensorimotor neu-
ropathy.
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Blood pressure was measured in the sitting position 
with a mercury sphygmomanometer with a cuff  ap-
propriate to the length and circumference of the arm 
after 10-min rest and expressed in mm Hg. Fasting 
venous blood samples were collected for determi nation 
of biochemistry panel, lipid profi le status and HbA1c. 
Serum cholesterol and triglycerides were measured by 
an enzymatic colorimetric method. HbA1c was mea-
sured spectrophotometrically by turbidimetric immu-
no-inhibition (Olympus AU600, Beckman-Coulter, 
USA).
Statistics
Baseline data on all patients were reported using 
descriptive statistics. Normality of distribution for 
continuous variables was analyzed using Shapiro-Wilk 
test. Normally distributed variables were described 
with mean and standard deviation (SD), while vari-
ables that were not normally distributed were de-
scribed with median, minimum and maximum. Nomi-
nal variables were reported with absolute numbers 
and/or percentages. Th e validity of each test was as-
sessed by the receiver operating characteristic (ROC) 
curves; the area under the curves (AUC) was calculat-
ed for each anthropometric parameter (BMI, WC, 
WHR and WHtR) and microvascular complication. 
Individual cutoff s, sensitivity and specifi city were esti-
mated by Youden index. Diff erences between AUCs 
were tested with nonparametric test30. AUC indicates 
a measure of degree of separation between aff ected and 
nonaff ected subjects by a specifi c test and the value of 
0.5 or lower indicates no discriminative value of the 
test used. Statistical interference is based on 95% con-
fi dence interval (CI) and 5% P values. Statistical anal-
ysis was conducted using the Statistical Package for 
Social Sciences (SPSS) ver. 17.0 and MedCalc 12.0 for 
Windows.
Results
Out of 125 T2DM study patients, there were 65 
(52%) male patients, median age 58 years with 11 years 
of disease duration. Table 1 summarizes descriptive 
anthropometric characteristics and biomedical data, as 
well as the prevalence of microvascular complications 
in all study subjects. Th e results of ROC analysis of the 
four anthropometric indices for three major microvas-
cular complications (CKD, retinopathy and peripheral 
neuropathy) are shown in Table 2. Th e AUC for 
WHtR was signifi cantly higher than the AUC for 
WC with respect to CKD. Th e AUC for peripheral 
neuropathy was signifi cant only for WHR. With 
 regard to retinopathy, there was no signifi cant diff er-
ence among the anthropometric parameters observed. 
Moreover, the AUCs suggested that these predictors 
should not be considered as validated tests. Table 3 
shows optimal cutoff s and their sensitivity and speci-
fi city for the parameters that showed validity accord-
ing to AUCs. Optimal cutoff  for WHtR was >0.593 
Table 1. Baseline characteristics of study subjects
N=125 
Age (years) 58 (31-76)
Disease duration (years) 11 (1-30)
HbA1c (%) 8.63±1.48
Weight (kg) 110 (78-187)
Body mass index (kg/m2) 35.57±5.36
Waist circumference (cm) 119 (88-192)
Hip circumference (cm) 116.5 (92-165)
Waist to hip ratio 1.005 
(0.795-1.401)
Waist to height ratio 0.674 
(0.321-1.091)
Systolic blood pressure (mm Hg) 140 (100-220)
Diastolic blood pressure (mm Hg) 90 (60-150)
Hypertension, n (%) 114 (91.2)
Total plasma cholesterol 
(mmol/L)
5.07 (3.02-7.41)
HDL cholesterol (mmol/L) 1.24 (0.70-2.49)
LDL cholesterol (mm Hg) 2.95 (1.03-5.81)
Triglycerides (mmol/L) 2.47 (0.76-10.83)
Dyslipidemia, n (%) 93 (74.4)
Serum creatinine (μmol/L) 74 (46-182)




Estimated GFR (mL/min/1.73 m2) 83 (41-118)
Current smoker, n (%) 105 (84)
Retinopathy prevalence, n (%) 45 (36)
Chronic kidney disease prevalence, 
n (%)
36 (28.8)
Peripheral neuropathy prevalence, 
n (%)
188 (94.4)
HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; LDL 
= low-density lipoprotein; GFR = glomerular fi ltration rate
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and for WC >112 cm regarding CKD. Both tests 
showed high to moderate sensitivity but low specifi ci-
ty. Optimal cutoff  for WHR regarding peripheral neu-
ropathy was >1.409 with low sensitivity and high spec-
ifi city.
Discussion
In this study on a representative sample of obese 
T2DM adults, we demonstrated that WC and WHtR 
were superior to BMI and WHR, and that WHtR was 
better than WC in discriminatory power for identify-
ing CKD, while WHR was superior to other estimates 
for identifi cation of peripheral neuropathy. Our study 
defi nitely supported the inconclusiveness of data on 
the relationship of BMI and microvascular complica-
tions31-37. It is known that anthropometric measure-
ments of BMI, WHR and WC do not correlate en-
tirely and are indices of diff erent aspects of obesity. For 
instance, adults with normal BMI may have markedly 
high anthropometric parameters of metabolic syn-
drome such as WC, sometimes referred to as meta-
bolically obese normal-weight adults38. As discussed in 
the Introduction section, other anthropometric mea-
surements of obesity also have limitations but have 
been proven to correlate more accurately with the 
amount of visceral adipose tissue39,40. Although the ex-
act pathophysiological pathway by which visceral adi-
pose tissue acts in the development of microvascular 
complications remains to be exactly defi ned, there are 
several hypotheses that link it with hypertension and 
dyslipidemia, which are confi rmed to be among the 
major risk factors that cause vascular injury and some 
other homeostasis disorders which might enhance the 
eff ect of these two16,25,39.
First, the hallmark of central obesity is insulin re-
sistance and because insulin is considered to be an 
anti-infl ammatory hormone, insulin resistance might 
be considered as a proinfl ammatory state and visceral 
adipocytes and macrophages are also a source of proin-
fl ammatory cytokines25. Th e common knowledge sug-
gests that they cause damage to endothelial cells and 




Waist to hip ratio Waist to height ratio
Body mass index 
(kg/m2)
Cut-off  Sens Spec Cut-off  Sens Spec Cut-off  Sens Spec Cut-off  Sens Spec
Chronic kidney disease >112 83.3 40.0 - >0.593 97.22 37.08 -
Retinopathy - - - -
Peripheral neuropathy - >1.049 33.3 100 - -
*Cut-off  was estimated by Youden index with equal weighted sensitivity and specifi city in ROC analysis (non validated tests were not 
 included in analysis)
Table 2. AUC estimated by ROC analysis
Waist circumference 
(cm)
Waist to hip ratio Waist to height ratio


































*p<0.05; AUC = area under curve; ROC analysis = Receiver Operating Characteristic analysis; 95% CI = 95% confi dence interval
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the process of atherogenesis in microcirculation be-
gins. Second, several studies have indicated that cen-
tral adipose tissue contributes to renin-angiotensin-
aldosterone system (RAAS) hormone disruption, i.e. 
increment in circulating levels of renin, angiotensino-
gen, angiotensin-converting enzyme, aldosterone, and 
angiotensin II26. Angiotensin II has been recognized 
as an important factor in raising intraglomerular pres-
sure in the kidney and induction of intrarenal infl am-
matory cytokines and growth factors which contribute 
to development and progression of hypertension. Th ere 
also are data indicating that angiotensin II contributes 
to cytokine production in visceral adipocytes, thus cre-
ating a circulus vitiosus in microvascular endothelium 
damage24. Dyslipidemia, defi ned as high total and low-
density lipoprotein cholesterol and low high-density 
lipoprotein cholesterol with race and gender defi ned 
cut-off s, is a well-documented phenomenon in visceral 
obesity, the role of which is unavoidable in vascular 
atherogenesis and development of microvascular com-
plications41. As discussed above, visceral fat is defi nite-
ly involved in the pathogenesis of cardiometabolic risk 
factors and thus search for the best noninvasive mea-
surements of visceral fat and their ability to predict 
cardiometabolic risk factors, development of diabetes 
and its chronic complications has recently come in the 
focus of interest worldwide. Th e majority of studies 
performed in healthy subjects and diabetic popula-
tion have found that WC, WHR and WhtR in par-
ticular are correlated with the mentioned out-
comes3,6,7,13,15,39,42-45. We did not fi nd any signifi cance in 
retinopathy prediction among analyzed indices, and 
the possible explanation is that it is a complication that 
involves more factors than others, since the data pub-
lished so far are most controversial of all17,18. Th e pos-
sibility of anthropometric measurements to predict 
peripheral neuropathy has been poorly investigated, 
but the data published to date might be in concor-
dance with our results, although they only indicate 
that these aspects of central obesity are associated with 
diabetic neuropathy19. Interestingly, similarly to our 
study results, Silva et al.43 evaluated the precision of 
diff erent anthropometric measures of abdominal adi-
posity in non-diabetic non-dialyzed patients with 
CKD. Th ey assessed the accuracy of the following an-
thropometric indices: WC, WHR, conicity index and 
WHtR to assess abdominal adiposity and compared 
them using trunk fat by dual x-ray absorptiometry 
(DXA) as a reference method; they also explored their 
association with insulin resistance (IR) using homeo-
stasis model assessment for IR index (HOMA-IR). 
Among studied indices, WHtR was the only one to 
show correlation with DXA trunk fat after adjusting 
for confounders and also indicated high HOMA-IR.
In conclusion, our study demonstrated that WHtR 
and WC might be used as simple and noninvasive 
methods for detection of CKD in obese T2DM popu-
lation and we even may suggest using these indices as 
simple and inexpensive methods in epidemiological 
studies. On the other hand, WHR could correctly 
identify all patients without peripheral neuropathy 
with 100% specifi city. However, there is a limitation 
regarding this result considering the high prevalence 
of the disease in our study population. It is important 
to emphasize that our study had several other limita-
tions, i.e. we did not make adjustments of the analyzed 
indices for the possible confounding factors that might 
contribute to development of microvascular complica-
tions, such as age, gender, diabetes duration or glyce-
mic control, and we strongly suggest additional studies 
to determine whether there is true association between 
obesity indices and microvascular complications in 
T2DM patients and which of them could be used as a 
simple method for detection of a particular microvas-
cular complication.
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Sažetak
UPOTREBA ANTROPOMETRIJSKIH OBILJEŽJA DEBLJINE 
U PROCJENI MIKROVASKULARNIH KOMPLIKACIJA 
U PRETILIH BOLESNIKA S TIPOM 2 ŠEĆERNE BOLESTI
T. Bulum, K. Blaslov i L. Duvnjak
Opseg struka (OS), omjer opsega struka i bokova (OSB) i omjer opsega struka i visine (OSV) su bolji predskazatelji 
razvoja šećerne bolesti tipa 2 (ŠB2) nego široko upotrebljavani indeks tjelesne mase (ITM). Svrha ovoga istraživanja je bila 
istražiti učinkovitost ITM, OS, OSB i OSV u procjeni učestalosti mikrovaskularnih komplikacija (kronična bubrežna bolest 
(KBB), retinopatija i periferna neuropatija) u pretilih (ITM ≥35 kg/m2) bolesnika sa ŠB2. Ova presječna studija je uključila 
125 bolesnika oba spola sa ŠB2. Dijagnostička vrijednost testova je procijenjena krivuljama ROC (engl. Receiver Operator 
Characteristic); područje ispod krivulje (AUC) je izračunato za svaki antropometrijski parametar i rizični čimbenik (mikrova-
skularnu komplikaciju). AUC za OSV je bio značajno viši nego AUC za OS za KBB. Optimalna granična vrijednost za OSV 
je bila >0,593, a za OS >112 cm za KBB. AUC za perifernu neuropatiju je bio značajan samo za OSB i optimalna granična 
vrijednost za OSB je bila >1,409, uz nisku osjetljivost i visoku specifi čnost. Rezultati našega istraživanja ukazuju na to da 
OSV, OS i OSB mogu biti jednostavna i neinvazivna metoda procjene učestalosti KBB i periferne neuropatije u pretilih 
bolesnika sa ŠB2.
Ključne riječi: Dijabetes melitus, tip 2; Pretilost – komplikacije; Struk, opseg; Struk-visina, odnos; Renalna insufi cijencija, 
 kronična; Dijabetička neuropatija; Dijabetička retinopatija
